NVO - Novo Nordisk A/S
This page shows which of the focused investors we track hold NVO and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2026 it was held by 4 managers with an aggregate reported value of $1.28B, which is 0.11% of the combined portfolio.
As of Q2 2026, 4 tracked institutional managers held NVO (Novo Nordisk A/S) with an aggregate reported value of $1.28B — 0.11% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades NVO — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2026
- Ticker
- NVO
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 0.51% | Add +5.5% | 20,397,110 | $977.84M |
| 2 | Thomas Gayner - Markel Asset Management | 1.05% | - | 2,869,774 | $137.58M |
| 3 | Sarah Ketterer - Causeway Capital Management | 0.87% | Add +42.9% | 1,677,615 | $80.42M |
| 4 | Lee Ainslie - Maverick Capital | 0.72% | Reduce -20.5% | 1,653,872 | $79.29M |
Loading holder history for NVO…